RightFit
RecruitingNot applicable

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The Functional Assessment of Cancer Therapy-Ovarian (FACT-O) QOL survey will be collected at baseline as well as 12 and 24 weeks after the initial course of adjuvant chemotherapy."
  • "The primary endpoint will be the 12-week survey."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether POSTCare-O support after initial ovarian cancer treatment improves quality of life. It is for 120 women who have finished their first treatment. Women will be placed by chance into POSTCare-O care or usual care, and quality of life will be checked 12 weeks later.

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have stage 2, 3, or 4 ovarian cancer.
  • Have been treated with a combination of surgery, chemotherapy, biologic drugs (drugs made from living sources), or maintenance treatment (ongoing treatment to help control cancer).
  • Finished initial treatment within the past 6 months. Ongoing maintenance treatment is okay.
  • Can give informed consent (agree to join after learning about the study) in English or Spanish.

Who can't join

  • Entered hospice care (care focused on comfort near the end of life) when ovarian cancer treatment ended.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Stage 2-4 ovarian cancer * Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy * Within 6 months of completion of initial treatment (continued maintenance therapy okay) * Able to provide consent in English or Spanish Exclusion Criteria: * Admission to hospice at the completion of treatment for ovary cancer

Study sites (3)

TX